EXHIBIT 11.1
ECLIPSE SURGICAL TECHNOLOGIES, INC.
STATEMENT REGARDING COMPUTATION OF NET LOSS PER SHARE
(in thousands, except per share amounts)
(unaudited)
THREE MONTHS ENDED SIX MONTHS ENDED
JUNE 30, JUNE 30,
----------------------- --------------------
1997 1996 1997 1996
-------- -------- -------- --------
Weighted average common shares outstanding for the
period ............................................ 16,284 11,033 16,233 10,751
Common equivalent shares pursuant to Staff
Accounting Bulletin No. 83......................... - 2,295 - 2,295
-------- ------- ------- -------
Shares used in per share calculations ............... 16,284 13,328 16,233 13,046
-------- ------- ------- -------
-------- ------- ------- -------
Net loss ............................................ $ (4,642) $ (730) $(8,499) $ (654)
-------- ------- ------- -------
-------- ------- ------- -------
Net loss per share .................................. $ (0.28 $ (0.05) $ (0.52) $ (0.05)
-------- ------- ------- -------
-------- ------- ------- -------
All share numbers reflect the Company's three-for-one stock split.
There is no difference between primary and fully diluted earnings per share for
each period presented.
20